Enteral Feeding Formulas Market By Product Type (Standard Formulas, Disease-specific Formulas, Peptide Based, Immune modulating, Blenderized), By Age Group (Adult, Child), By Application (Cancer, Neurological Disorders, Gastrointestinal Disorders, Malnutrition, Others), By End user (Hospital, Long term Care Facilities, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Enteral Feeding Formulas Market

Enteral feeding formulas, also known as enteral nutrition or tube feeding formulas, are specially designed nutritional products that are used to provide essential nutrients to individuals who are unable to consume food orally or have difficulty in doing so. This can include patients with various medical conditions such as gastrointestinal disorders, cancer, neurological disorders, or those recovering from surgery. Enteral feeding formulas are typically administered through a tube, such as a nasogastric tube, gastrostomy tube, or jejunostomy tube. 

Key factors driving the growth of the enteral feeding formulas market include to surge in the geriatric population, and a rise in the global prevalence of chronic diseases such as gastrointestinal disorders, cancers, and neurological disorders.

The surge in the geriatric population has emerged as a significant driver for the enteral feeding formula market. This trend is a reflection of the global demographic shift towards an aging society, where a larger proportion of the population is reaching the elderly stage of life. For instance, according to the World Health Organization, in 2020, the number of people aged 60 years and older outnumbered children younger than 5 years.  As individuals age, they often experience a range of health issues that can make it challenging to maintain adequate nutrition through regular dietary means. Elderly people face difficulties in chewing, swallowing, or digesting food, which can lead to malnutrition and related health complications. Consequently, healthcare providers increasingly turn to enteral feeding formulas as a viable solution to ensure that elderly patients receive the necessary nutrients and calories they require for proper nourishment.  The demand for enteral feeding formulas is further accentuated by the growing recognition of the importance of specialized nutrition for the elderly population. These formulations are tailored to address the unique dietary needs and medical conditions that often accompany aging, such as reduced muscle mass, compromised immune systems, and chronic illnesses like diabetes and gastrointestinal disorders. Moreover, the convenience and ease of administration of enteral feeding formulas make them an attractive option for both caregivers and healthcare facilities, as they can be administered through feeding tubes or oral supplements. Thus, the rise in geriatric population is expected to drive the growth of the market.Furthermore, the global prevalence of chronic diseases has been steadily rising, and this alarming trend has emerged as a major driver for the enteral feeding formula market. Chronic diseases, such as diabetes, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), and cancer, have become increasingly common across the world due to factors like sedentary lifestyles, poor dietary choices, and an aging population. For instance, in 2023, the American Cancer Society estimated that around 1,958,310 new cancer cases in the U.S. These conditions often result in compromised nutritional status and difficulty in maintaining adequate oral food intake, leading to malnutrition. As a result, there is a growing need for specialized nutritional support, and enteral feeding formulas have gained prominence as a vital solution. Patients often experience difficulties in maintaining a balanced diet, leading to malnutrition and complications. Enteral feeding formulas are specially designed liquid nutrition supplements that are administered through tubes directly into the digestive tract. They are tailored to meet the specific dietary needs of individuals who are unable to consume regular food or absorb nutrients adequately through their digestive system.

The enteral feeding formulas market is segmented on the basis of product type, age group, application, end user, and region. By product type, the market is categorized into the standard formula, disease-specific formulas, peptide-based, and immune-modulating, blenderized. By age group, the market is categorized into adults and children. By application, the market is categorized into cancer, neurological disorders, gastrointestinal disorders, malnutrition, and others. By end user, the market is categorized into hospitals, long-term care facilities, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The key players profiled in the study include Abbott Laboratories, Nestlé, Danone S.A, Fresenius SE and Co. KGaA, B. Braun SE, Otsuka Holdings, Nutritional Medicinals, LLC, Kate Farms, Global Health Products Inc, and DermaRite Industries, LLC.

Key Market Insights 

On the basis of product type, the standard formula segment was the highest contributor to the market in 2022. However, the disease-specific formulas segment is expected to register the fastest growth during the forecasted period.

On the basis of age group, the adult was the highest contributor to the market in 2022.

On the basis of end users, the hospital segment was the highest contributor to the market in 2022.

On the basis of region, Europe generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. 

Overview

The global enteral feeding formulas market was valued at $6,298.6 million in 2022 and is projected to reach $ 12,706.8 million by 2032, registering a CAGR of 7.4% from 2023 to 2032.

Enteral feeding formulas, also known as tube feeding formulas, are specialized nutritional solutions designed for individuals who cannot consume food orally or have difficulty swallowing. These formulas are primarily used to provide essential nutrients, calories, vitamins, and minerals to patients who rely on tube feeding as their primary source of nutrition. Enteral feeding formulas come in various formulations to meet the specific nutritional needs of different patient populations, such as infants, adults, and elderly individuals. Key factors driving the growth of the enteral feeding formula market are the rise in the geriatric population and the surge in the prevalence of chronic diseases such as cancer, gastrointestinal disorders, and neurological conditions.

The escalating growth of the geriatric population has emerged as a significant driving force behind the expansion of the enteral feeding formula market. In recent years, the world has witnessed a remarkable increase in the number of elderly individuals, primarily attributed to advancements in medical care and a rise in life expectancy. According to United Nations World Population Prospects 2022, in 2022, there were 771 million people aged 65 years or over globally and the older population is projected to reach 994 million by 2030 and 1.6 billion by 2050. As people age, they often encounter various health challenges that can lead to difficulties in maintaining proper nutrition through regular dietary intake. Enteral feeding formulas are designed to provide essential nutrients directly to the digestive system, bypassing any potential obstacles that might hinder nutrient absorption or intake. Given that the elderly population is more susceptible to conditions that can impede their ability to consume a balanced diet, such as dysphagia, neurological disorders, or chronic illnesses, the demand for enteral feeding formulas has surged significantly. Elderly individuals frequently experience medical conditions that can diminish their appetite, impair their ability to swallow or reduce their capacity to absorb nutrients efficiently. As a result, healthcare professionals often turn to enteral feeding formulas to bridge these nutritional gaps and prevent malnutrition, which is a common concern among the elderly. Moreover, the convenience and precision of enteral feeding formulas make them an attractive option for both patients and caregivers. These formulas can be tailored to meet specific dietary requirements and health needs, ensuring that individuals receive the appropriate mix of vitamins, minerals, proteins, and calories. Thus, the rise in the geriatric population has emerged as a major catalyst for the expansion of the enteral feeding formula market.

Furthermore, the surge in the prevalence of chronic diseases such as cancer, gastrointestinal disorders, and neurological conditions has also emerged as a major driver for the enteral feeding formula market. Chronic diseases, such as diabetes, cancer, cardiovascular diseases, and neurological disorders, have become increasingly prevalent across various demographics, encompassing both developed and developing nations. This rise can be attributed to factors such as changing lifestyles, aging populations, and environmental influences. According to the American Cancer Society, in 2023, an estimated 12,380 new cases of laryngeal cancer were recorded. In addition, according to MedlinePlus, in 2022, it was estimated that more than half a million Americans are currently affected by this disorder. In many chronic diseases, patients often experience compromised nutritional status due to various reasons, including reduced appetite, difficulty swallowing, impaired digestion, and nutrient malabsorption. This necessitates the utilization of enteral feeding, which involves the delivery of nutrients directly into the gastrointestinal tract through a feeding tube. Enteral feeding formulas play a pivotal role in ensuring that patients receive the required nutrients, vitamins, and minerals in a controlled and easily digestible form. These formulas are specially designed to cater to the specific nutritional needs of patients with chronic diseases, addressing their medical condition while also supporting overall health and well-being. The integration of nutrition as a crucial component of chronic disease management further underscores the importance of enteral feeding formulas in improving patient outcomes and quality of life. Thus, the rise in the prevalence of chronic diseases is expected to drive the growth of the market. However, patient incompatibility and allergies might act as restraints for the enteral feeding formulas.

The enteral feeding formulas market is segmented on the basis of product type, age group, application, end user, and region. By product type, the market is categorized into standard formula, disease-specific formulas, peptide-based, and immune-modulating, blenderized. By age group, the market is categorized into adults and children. By application, the market is categorized into cancer, neurological disorders, gastrointestinal disorders, malnutrition, and others. By end user, the market is categorized into hospitals, long-term care facilities, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global enteral feeding formulas market are Abbott Laboratories, Nestlé, Danone S.A, Fresenius SE and Co. KGaA, B. Braun SE, Otsuka Holdings, Nutritional Medicinals, LLC, Kate Farms, Global Health Products Inc, DermaRite Industries, LLC.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the enteral feeding formulas market analysis from 2022 to 2032 to identify the prevailing enteral feeding formulas market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.

An in-depth analysis of the enteral feeding formulas market segmentation assists in determining the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes an analysis of the regional as well as global enteral feeding formulas market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

● Quarterly Update and* (only available with a corporate license, on listed price)

● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.

● Free Upcoming Version on the Purchase of Five and Enterprise User License.

● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)

● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)

● Free data Pack on the Five and Enterprise User License. (Excel version of the report)

● Free Updated report if the report is 6-12 months old or older.

● 24-hour priority response*

● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

● Additional company profiles with specific to client's interest

● Additional country or region analysis- market size and forecast

● Average Selling Price Analysis / Price Point Analysis

● Criss-cross segment analysis- market size and forecast

● Expanded list for Company Profiles

● Historic market data

● Key player details (including location, contact details, supplier/vendor network etc. in excel format)

● Market share analysis of players at global/region/country level

● SWOT Analysis

● Volume Market Size and Forecast

Key Market Segments

○ Danone S.

Scope of Enteral Feeding Formulas Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Low bargaining power of suppliers

3.3.2. Low threat of new entrants

3.3.3. Low threat of substitutes

3.3.4. Low intensity of rivalry

3.3.5. Low bargaining power of buyers

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Surge in number of preterm births.

3.4.1.2. Rise in geriatric population.

3.4.1.3. Rise in prevalence of chronic disease.

3.4.2. Restraints

3.4.2.1. Low patient acceptance

3.4.3. Opportunities

3.4.3.1. Opportunities in the emerging markets

4.1. Overview

4.1.1. Market size and forecast

4.2. Standard Formulas

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Disease-specific Formulas

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Peptide Based

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

4.5. Immune modulating

4.5.1. Key market trends, growth factors and opportunities

4.5.2. Market size and forecast, by region

4.5.3. Market share analysis by country

4.6. Blenderized

4.6.1. Key market trends, growth factors and opportunities

4.6.2. Market size and forecast, by region

4.6.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Adult

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Child

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Cancer

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Neurological Disorders

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Gastrointestinal Disorders

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

6.5. Malnutrition

6.5.1. Key market trends, growth factors and opportunities

6.5.2. Market size and forecast, by region

6.5.3. Market share analysis by country

6.6. Others

6.6.1. Key market trends, growth factors and opportunities

6.6.2. Market size and forecast, by region

6.6.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast

7.2. Hospital

7.2.1. Key market trends, growth factors and opportunities

7.2.2. Market size and forecast, by region

7.2.3. Market share analysis by country

7.3. Long term Care Facilities

7.3.1. Key market trends, growth factors and opportunities

7.3.2. Market size and forecast, by region

7.3.3. Market share analysis by country

7.4. Others

7.4.1. Key market trends, growth factors and opportunities

7.4.2. Market size and forecast, by region

7.4.3. Market share analysis by country

8.1. Overview

8.1.1. Market size and forecast By Region

8.2. North America

8.2.1. Key market trends, growth factors and opportunities

8.2.2. Market size and forecast, by Product Type

8.2.3. Market size and forecast, by Age Group

8.2.4. Market size and forecast, by Application

8.2.5. Market size and forecast, by End user

8.2.6. Market size and forecast, by country

8.2.6.1. U.S.

8.2.6.1.1. Market size and forecast, by Product Type

8.2.6.1.2. Market size and forecast, by Age Group

8.2.6.1.3. Market size and forecast, by Application

8.2.6.1.4. Market size and forecast, by End user

8.2.6.2. Canada

8.2.6.2.1. Market size and forecast, by Product Type

8.2.6.2.2. Market size and forecast, by Age Group

8.2.6.2.3. Market size and forecast, by Application

8.2.6.2.4. Market size and forecast, by End user

8.2.6.3. Mexico

8.2.6.3.1. Market size and forecast, by Product Type

8.2.6.3.2. Market size and forecast, by Age Group

8.2.6.3.3. Market size and forecast, by Application

8.2.6.3.4. Market size and forecast, by End user

8.3. Europe

8.3.1. Key market trends, growth factors and opportunities

8.3.2. Market size and forecast, by Product Type

8.3.3. Market size and forecast, by Age Group

8.3.4. Market size and forecast, by Application

8.3.5. Market size and forecast, by End user

8.3.6. Market size and forecast, by country

8.3.6.1. Germany

8.3.6.1.1. Market size and forecast, by Product Type

8.3.6.1.2. Market size and forecast, by Age Group

8.3.6.1.3. Market size and forecast, by Application

8.3.6.1.4. Market size and forecast, by End user

8.3.6.2. France

8.3.6.2.1. Market size and forecast, by Product Type

8.3.6.2.2. Market size and forecast, by Age Group

8.3.6.2.3. Market size and forecast, by Application

8.3.6.2.4. Market size and forecast, by End user

8.3.6.3. UK

8.3.6.3.1. Market size and forecast, by Product Type

8.3.6.3.2. Market size and forecast, by Age Group

8.3.6.3.3. Market size and forecast, by Application

8.3.6.3.4. Market size and forecast, by End user

8.3.6.4. Italy

8.3.6.4.1. Market size and forecast, by Product Type

8.3.6.4.2. Market size and forecast, by Age Group

8.3.6.4.3. Market size and forecast, by Application

8.3.6.4.4. Market size and forecast, by End user

8.3.6.5. Spain

8.3.6.5.1. Market size and forecast, by Product Type

8.3.6.5.2. Market size and forecast, by Age Group

8.3.6.5.3. Market size and forecast, by Application

8.3.6.5.4. Market size and forecast, by End user

8.3.6.6. Rest of Europe

8.3.6.6.1. Market size and forecast, by Product Type

8.3.6.6.2. Market size and forecast, by Age Group

8.3.6.6.3. Market size and forecast, by Application

8.3.6.6.4. Market size and forecast, by End user

8.4. Asia-Pacific

8.4.1. Key market trends, growth factors and opportunities

8.4.2. Market size and forecast, by Product Type

8.4.3. Market size and forecast, by Age Group

8.4.4. Market size and forecast, by Application

8.4.5. Market size and forecast, by End user

8.4.6. Market size and forecast, by country

8.4.6.1. Japan

8.4.6.1.1. Market size and forecast, by Product Type

8.4.6.1.2. Market size and forecast, by Age Group

8.4.6.1.3. Market size and forecast, by Application

8.4.6.1.4. Market size and forecast, by End user

8.4.6.2. China

8.4.6.2.1. Market size and forecast, by Product Type

8.4.6.2.2. Market size and forecast, by Age Group

8.4.6.2.3. Market size and forecast, by Application

8.4.6.2.4. Market size and forecast, by End user

8.4.6.3. Australia

8.4.6.3.1. Market size and forecast, by Product Type

8.4.6.3.2. Market size and forecast, by Age Group

8.4.6.3.3. Market size and forecast, by Application

8.4.6.3.4. Market size and forecast, by End user

8.4.6.4. India

8.4.6.4.1. Market size and forecast, by Product Type

8.4.6.4.2. Market size and forecast, by Age Group

8.4.6.4.3. Market size and forecast, by Application

8.4.6.4.4. Market size and forecast, by End user

8.4.6.5. South Korea

8.4.6.5.1. Market size and forecast, by Product Type

8.4.6.5.2. Market size and forecast, by Age Group

8.4.6.5.3. Market size and forecast, by Application

8.4.6.5.4. Market size and forecast, by End user

8.4.6.6. Rest of Asia-Pacific

8.4.6.6.1. Market size and forecast, by Product Type

8.4.6.6.2. Market size and forecast, by Age Group

8.4.6.6.3. Market size and forecast, by Application

8.4.6.6.4. Market size and forecast, by End user

8.5. LAMEA

8.5.1. Key market trends, growth factors and opportunities

8.5.2. Market size and forecast, by Product Type

8.5.3. Market size and forecast, by Age Group

8.5.4. Market size and forecast, by Application

8.5.5. Market size and forecast, by End user

8.5.6. Market size and forecast, by country

8.5.6.1. Brazil

8.5.6.1.1. Market size and forecast, by Product Type

8.5.6.1.2. Market size and forecast, by Age Group

8.5.6.1.3. Market size and forecast, by Application

8.5.6.1.4. Market size and forecast, by End user

8.5.6.2. Saudi Arabia

8.5.6.2.1. Market size and forecast, by Product Type

8.5.6.2.2. Market size and forecast, by Age Group

8.5.6.2.3. Market size and forecast, by Application

8.5.6.2.4. Market size and forecast, by End user

8.5.6.3. South Africa

8.5.6.3.1. Market size and forecast, by Product Type

8.5.6.3.2. Market size and forecast, by Age Group

8.5.6.3.3. Market size and forecast, by Application

8.5.6.3.4. Market size and forecast, by End user

8.5.6.4. Rest of LAMEA

8.5.6.4.1. Market size and forecast, by Product Type

8.5.6.4.2. Market size and forecast, by Age Group

8.5.6.4.3. Market size and forecast, by Application

8.5.6.4.4. Market size and forecast, by End user

9.1. Introduction

9.2. Top winning strategies

9.3. Product mapping of top 10 player

9.4. Competitive dashboard

9.5. Competitive heatmap

9.6. Top player positioning, 2022

10.1. Abbott Laboratories

10.1.1. Company overview

10.1.2. Key executives

10.1.3. Company snapshot

10.1.4. Operating business segments

10.1.5. Product portfolio

10.1.6. Business performance

10.1.7. Key strategic moves and developments

10.2. B. Braun Melsungen AG

10.2.1. Company overview

10.2.2. Key executives

10.2.3. Company snapshot

10.2.4. Operating business segments

10.2.5. Product portfolio

10.2.6. Business performance

10.3. Meiji Holdings Co. Ltd

10.3.1. Company overview

10.3.2. Key executives

10.3.3. Company snapshot

10.3.4. Operating business segments

10.3.5. Product portfolio

10.3.6. Business performance

10.3.7. Key strategic moves and developments

10.4. Nestle SA

10.4.1. Company overview

10.4.2. Key executives

10.4.3. Company snapshot

10.4.4. Operating business segments

10.4.5. Product portfolio

10.4.6. Business performance

10.5. Hormel Foods Corporation

10.5.1. Company overview

10.5.2. Key executives

10.5.3. Company snapshot

10.5.4. Operating business segments

10.5.5. Product portfolio

10.5.6. Business performance

10.6. Fresenius SE & Co. KGaA

10.6.1. Company overview

10.6.2. Key executives

10.6.3. Company snapshot

10.6.4. Operating business segments

10.6.5. Product portfolio

10.6.6. Business performance

10.7. Medtrition Inc.

10.7.1. Company overview

10.7.2. Key executives

10.7.3. Company snapshot

10.7.4. Operating business segments

10.7.5. Product portfolio

10.8. Nutritional Medicinals, LLC

10.8.1. Company overview

10.8.2. Key executives

10.8.3. Company snapshot

10.8.4. Operating business segments

10.8.5. Product portfolio

10.9. DermaRite Industries, LLC.

10.9.1. Company overview

10.9.2. Key executives

10.9.3. Company snapshot

10.9.4. Operating business segments

10.9.5. Product portfolio

10.10. Danone S.A

10.10.1. Company overview

10.10.2. Key executives

10.10.3. Company snapshot

10.10.4. Operating business segments

10.10.5. Product portfolio

10.10.6. Business performanc

LIST OF TABLES

TABLE 01. GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 02. ENTERAL FEEDING FORMULAS MARKET FOR STANDARD FORMULAS, BY REGION, 2022-2032 ($MILLION)

TABLE 03. ENTERAL FEEDING FORMULAS MARKET FOR DISEASE-SPECIFIC FORMULAS, BY REGION, 2022-2032 ($MILLION)

TABLE 04. ENTERAL FEEDING FORMULAS MARKET FOR PEPTIDE BASED, BY REGION, 2022-2032 ($MILLION)

TABLE 05. ENTERAL FEEDING FORMULAS MARKET FOR IMMUNE MODULATING, BY REGION, 2022-2032 ($MILLION)

TABLE 06. ENTERAL FEEDING FORMULAS MARKET FOR BLENDERIZED, BY REGION, 2022-2032 ($MILLION)

TABLE 07. GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 08. ENTERAL FEEDING FORMULAS MARKET FOR ADULT, BY REGION, 2022-2032 ($MILLION)

TABLE 09. ENTERAL FEEDING FORMULAS MARKET FOR CHILD, BY REGION, 2022-2032 ($MILLION)

TABLE 10. GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 11. ENTERAL FEEDING FORMULAS MARKET FOR CANCER, BY REGION, 2022-2032 ($MILLION)

TABLE 12. ENTERAL FEEDING FORMULAS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2022-2032 ($MILLION)

TABLE 13. ENTERAL FEEDING FORMULAS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2022-2032 ($MILLION)

TABLE 14. ENTERAL FEEDING FORMULAS MARKET FOR MALNUTRITION, BY REGION, 2022-2032 ($MILLION)

TABLE 15. ENTERAL FEEDING FORMULAS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 16. GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 17. ENTERAL FEEDING FORMULAS MARKET FOR HOSPITAL, BY REGION, 2022-2032 ($MILLION)

TABLE 18. ENTERAL FEEDING FORMULAS MARKET FOR LONG TERM CARE FACILITIES, BY REGION, 2022-2032 ($MILLION)

TABLE 19. ENTERAL FEEDING FORMULAS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 20. ENTERAL FEEDING FORMULAS MARKET, BY REGION, 2022-2032 ($MILLION)

TABLE 21. NORTH AMERICA ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 22. NORTH AMERICA ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 23. NORTH AMERICA ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 24. NORTH AMERICA ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 25. NORTH AMERICA ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 26. U.S. ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 27. U.S. ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 28. U.S. ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 29. U.S. ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 30. CANADA ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 31. CANADA ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 32. CANADA ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 33. CANADA ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 34. MEXICO ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 35. MEXICO ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 36. MEXICO ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 37. MEXICO ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 38. EUROPE ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 39. EUROPE ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 40. EUROPE ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 41. EUROPE ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 42. EUROPE ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 43. GERMANY ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 44. GERMANY ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 45. GERMANY ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 46. GERMANY ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 47. FRANCE ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 48. FRANCE ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 49. FRANCE ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 50. FRANCE ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 51. UK ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 52. UK ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 53. UK ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 54. UK ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 55. ITALY ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 56. ITALY ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 57. ITALY ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 58. ITALY ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 59. SPAIN ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 60. SPAIN ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 61. SPAIN ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 62. SPAIN ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 63. REST OF EUROPE ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 64. REST OF EUROPE ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 65. REST OF EUROPE ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 66. REST OF EUROPE ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 67. ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 68. ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 69. ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 70. ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 71. ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 72. JAPAN ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 73. JAPAN ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 74. JAPAN ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 75. JAPAN ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 76. CHINA ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 77. CHINA ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 78. CHINA ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 79. CHINA ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 80. AUSTRALIA ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 81. AUSTRALIA ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 82. AUSTRALIA ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 83. AUSTRALIA ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 84. INDIA ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 85. INDIA ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 86. INDIA ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 87. INDIA ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 88. SOUTH KOREA ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 89. SOUTH KOREA ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 90. SOUTH KOREA ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 91. SOUTH KOREA ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 92. REST OF ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 93. REST OF ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 94. REST OF ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 95. REST OF ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 96. LAMEA ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 97. LAMEA ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 98. LAMEA ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 99. LAMEA ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 100. LAMEA ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 101. BRAZIL ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 102. BRAZIL ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 103. BRAZIL ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 104. BRAZIL ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 105. SAUDI ARABIA ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 106. SAUDI ARABIA ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 107. SAUDI ARABIA ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 108. SAUDI ARABIA ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 109. SOUTH AFRICA ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 110. SOUTH AFRICA ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 111. SOUTH AFRICA ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 112. SOUTH AFRICA ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 113. REST OF LAMEA ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 114. REST OF LAMEA ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022-2032 ($MILLION)

TABLE 115. REST OF LAMEA ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 116. REST OF LAMEA ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 117. ABBOTT LABORATORIES: KEY EXECUTIVES

TABLE 118. ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 119. ABBOTT LABORATORIES: PRODUCT SEGMENTS

TABLE 120. ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 121. ABBOTT LABORATORIES: KEY STRATERGIES

TABLE 122. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES

TABLE 123. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT

TABLE 124. B. BRAUN MELSUNGEN AG: PRODUCT SEGMENTS

TABLE 125. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO

TABLE 126. MEIJI HOLDINGS CO. LTD: KEY EXECUTIVES

TABLE 127. MEIJI HOLDINGS CO. LTD: COMPANY SNAPSHOT

TABLE 128. MEIJI HOLDINGS CO. LTD: PRODUCT SEGMENTS

TABLE 129. MEIJI HOLDINGS CO. LTD: PRODUCT PORTFOLIO

TABLE 130. MEIJI HOLDINGS CO. LTD: KEY STRATERGIES

TABLE 131. NESTLE SA: KEY EXECUTIVES

TABLE 132. NESTLE SA: COMPANY SNAPSHOT

TABLE 133. NESTLE SA: PRODUCT SEGMENTS

TABLE 134. NESTLE SA: PRODUCT PORTFOLIO

TABLE 135. HORMEL FOODS CORPORATION: KEY EXECUTIVES

TABLE 136. HORMEL FOODS CORPORATION: COMPANY SNAPSHOT

TABLE 137. HORMEL FOODS CORPORATION: PRODUCT SEGMENTS

TABLE 138. HORMEL FOODS CORPORATION: PRODUCT PORTFOLIO

TABLE 139. FRESENIUS SE & CO. KGAA: KEY EXECUTIVES

TABLE 140. FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT

TABLE 141. FRESENIUS SE & CO. KGAA: PRODUCT SEGMENTS

TABLE 142. FRESENIUS SE & CO. KGAA: PRODUCT PORTFOLIO

TABLE 143. MEDTRITION INC.: KEY EXECUTIVES

TABLE 144. MEDTRITION INC.: COMPANY SNAPSHOT

TABLE 145. MEDTRITION INC.: PRODUCT SEGMENTS

TABLE 146. MEDTRITION INC.: PRODUCT PORTFOLIO

TABLE 147. NUTRITIONAL MEDICINALS, LLC: KEY EXECUTIVES

TABLE 148. NUTRITIONAL MEDICINALS, LLC: COMPANY SNAPSHOT

TABLE 149. NUTRITIONAL MEDICINALS, LLC: PRODUCT SEGMENTS

TABLE 150. NUTRITIONAL MEDICINALS, LLC: PRODUCT PORTFOLIO

TABLE 151. DERMARITE INDUSTRIES, LLC.: KEY EXECUTIVES

TABLE 152. DERMARITE INDUSTRIES, LLC.: COMPANY SNAPSHOT

TABLE 153. DERMARITE INDUSTRIES, LLC.: PRODUCT SEGMENTS

TABLE 154. DERMARITE INDUSTRIES, LLC.: PRODUCT PORTFOLIO

TABLE 155. DANONE S.A: KEY EXECUTIVES

TABLE 156. DANONE S.A: COMPANY SNAPSHOT

TABLE 157. DANONE S.A: PRODUCT SEGMENTS

TABLE 158. DANONE S.A: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. ENTERAL FEEDING FORMULAS MARKET, 2022-2032

FIGURE 02. SEGMENTATION OF ENTERAL FEEDING FORMULAS MARKET,2022-2032

FIGURE 03. TOP IMPACTING FACTORS IN ENTERAL FEEDING FORMULAS MARKET (2012 TO 2022)

FIGURE 04. TOP INVESTMENT POCKETS IN ENTERAL FEEDING FORMULAS MARKET (2023-2032)

FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 06. LOW THREAT OF NEW ENTRANTS

FIGURE 07. LOW THREAT OF SUBSTITUTES

FIGURE 08. LOW INTENSITY OF RIVALRY

FIGURE 09. LOW BARGAINING POWER OF BUYERS

FIGURE 10. GLOBAL ENTERAL FEEDING FORMULAS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 11. ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE, 2022 AND 2032(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR STANDARD FORMULAS, BY COUNTRY 2022 AND 2032(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR DISEASE-SPECIFIC FORMULAS, BY COUNTRY 2022 AND 2032(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR PEPTIDE BASED, BY COUNTRY 2022 AND 2032(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR IMMUNE MODULATING, BY COUNTRY 2022 AND 2032(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR BLENDERIZED, BY COUNTRY 2022 AND 2032(%)

FIGURE 17. ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP, 2022 AND 2032(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR ADULT, BY COUNTRY 2022 AND 2032(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR CHILD, BY COUNTRY 2022 AND 2032(%)

FIGURE 20. ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022 AND 2032(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR CANCER, BY COUNTRY 2022 AND 2032(%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR GASTROINTESTINAL DISORDERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR MALNUTRITION, BY COUNTRY 2022 AND 2032(%)

FIGURE 25. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 26. ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022 AND 2032(%)

FIGURE 27. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR HOSPITAL, BY COUNTRY 2022 AND 2032(%)

FIGURE 28. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR LONG TERM CARE FACILITIES, BY COUNTRY 2022 AND 2032(%)

FIGURE 29. COMPARATIVE SHARE ANALYSIS OF ENTERAL FEEDING FORMULAS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 30. ENTERAL FEEDING FORMULAS MARKET BY REGION, 2022 AND 2032(%)

FIGURE 31. U.S. ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 32. CANADA ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 33. MEXICO ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 34. GERMANY ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 35. FRANCE ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 36. UK ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 37. ITALY ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 38. SPAIN ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 39. REST OF EUROPE ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 40. JAPAN ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 41. CHINA ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 42. AUSTRALIA ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 43. INDIA ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 44. SOUTH KOREA ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 45. REST OF ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 46. BRAZIL ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 47. SAUDI ARABIA ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 48. SOUTH AFRICA ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 49. REST OF LAMEA ENTERAL FEEDING FORMULAS MARKET, 2022-2032 ($MILLION)

FIGURE 50. TOP WINNING STRATEGIES, BY YEAR (2022-2022)

FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT (2022-2022)

FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY (2022-2022)

FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 54. COMPETITIVE DASHBOARD

FIGURE 55. COMPETITIVE HEATMAP: ENTERAL FEEDING FORMULAS MARKET

FIGURE 56. TOP PLAYER POSITIONING, 2022

FIGURE 57. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)

FIGURE 58. ABBOTT LABORATORIES: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)

FIGURE 59. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 60. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 61. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)

FIGURE 62. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 63. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 64. MEIJI HOLDINGS CO. LTD: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 65. MEIJI HOLDINGS CO. LTD: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 66. NESTLE SA: NET SALES, 2020-2022 ($MILLION)

FIGURE 67. NESTLE SA: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 68. NESTLE SA: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 69. HORMEL FOODS CORPORATION: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 70. HORMEL FOODS CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 71. HORMEL FOODS CORPORATION: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 72. FRESENIUS SE & CO. KGAA: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 73. FRESENIUS SE & CO. KGAA: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 74. FRESENIUS SE & CO. KGAA: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 75. DANONE S.A: NET SALES, 2020-2022 ($MILLION)

FIGURE 76. DANONE S.A: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 77. DANONE S.A: REVENUE SHARE BY REGION, 2022 (%